Newscasts - Pluses and minuses of the weight-loss drug bonanza

Fresenius SE & Co. KGaA

18/11/2025 04:33

Click the following link to watch video: https://share.newscasts.refinitiv.com/link?entryId=1_7nbeu4wk&referenceId=d9a81a8a-c436-11f0-b59f-b3017843011b_B30&pageId=Newscasts
Source: 'Reuters - General news videos'

Description: Obesity treatments made by Novo Nordisk and Eli Lilly have spawned a healthcare revolution, with sales set to hit $150 bln by 2031. In this episode of The Big View, Peter Thal Larsen talks to Breakingviews Associate Editor Aimee Donnellan about their origins – and their impact.Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising.Learn more about your ad choices. Visit megaphone.fm/adchoices

Short Link: https://lseg.group/3LIPWvY

Video Transcript:

Verified transcript not available